Valve loader method, system, and apparatus

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Spiration, Inc. patent solves the following problem:

Embodiments of the invention generally relates to the field of medical devices, and in particular, the methods, systems, and devices for loading or introducing into a catheter with a valve or stent for implantation into in one body.

Our analysis of this patent is as follows:

Spiration, Inc.’s patent US 8043301 B2 deals with Valve loader method, system, and apparatus.
A valve loading system which uses a valve loader to move a valve or other medical device from one storage cartridge to a deployment catheter. The valve or other medical device to be placed or positioned in a patient using the catheter after the valve or other medical device to be compressed and loaded into the catheter using the loader valve. The process will be repeated by using the valve loading system to load or make another valve or other medical device to the catheter.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

System and method for generating a photograph with variable image quality

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Sony Ericsson Mobile Communications Ab patent solves the following problem:

Mobile and / or wireless electronic devices are becoming increasingly popular. For example, the mobile phone, portable media players and portable gaming devices now in wide-spread use. Furthermore, the part associated with certain types of electronic devices become more diverse. For example, many mobile phones now include cameras that can capture still images and video images.

Our analysis of this patent is as follows:

Sony Ericsson Mobile Communications Ab’s patent US 8045799 B2 deals with System and method for generating a photograph with variable image quality.
Image data for a digital picture of it into a first portion and a second portion. The image data processed in the second half of a quality less than the data in the first place. A file picture of the scene that kept where the image file includes image data corresponding to the first and second part is that the image file that has a high quality side and a low quality parts.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Determining the capability of a test compound to affect solid tumor stem cells

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The The Regents Of The University Of Michigan patent solves the following problem:

Cancer remains the number two cause of death in this country, resulting in more than 500,000 deaths each year. Despite progress in detection and treatment, cancer mortality remains high. Despite remarkable progress in understanding the molecular basis of cancer, this knowledge has not yet translated into effective therapeutic strategies.

Our analysis of this patent is as follows:

The Regents Of The University Of Michigan’s patent US 8044259 B2 deals with Determining the capability of a test compound to affect solid tumor stem cells.
A small percentage of cells in a firm with strong tumor properties of stem cells. These strong tumor stem cells give rise to two more tumor stem cells and the majority of tumor cells that have lost the capacity for growth and the ability to give rise to new tumors. Therefore, strong tumor heterogeneity appeared before the tumor cell line arising from a strong tumor stem cells. A xenograft model in which we can build in tumors from primary tumors by injection of tumor cells in mammary England severely immunodeficient mice. These xenograft assay allows us to do the biological and molecular assays virtue clonogenic strong tumor stem cells. We also found evidence that strongly implicates the notch road, especially to notch 4, as playing a central pathway of carcinogenesis.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Semiconductor manufacturing method and semiconductor device

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Kabushiki Kaisha Toshiba patent solves the following problem:

The present invention relates to a method for manufacturing a semiconductor device and semiconductor devices, and particularly to a method for manufacturing a semiconductor device having a metal oxide semiconductor field effect transistor ( MOSFET) provided in a projecting semiconductor layer, and the semiconductor device.

Our analysis of this patent is as follows:

Kabushiki Kaisha Toshiba’s patent US 8043904 B2 deals with Semiconductor manufacturing method and semiconductor device.
A method of manufacturing a semiconductor device includes forming a mask layer on a first conductivity type semiconductor substrate, etching the semiconductor substrate using the mask layer as a mask, thus forming a projecting semiconductor layer, forming a first insulating layer on the semiconductor substrate to cover a lower projecting semiconductor layer, doping a first-conductivity-type impurity in the first insulating layer, thus forming a high-impurity-concentration layer lower projecting semiconductor layer, forming gate insulating films on the side of the projecting semiconductor layer upwardly extend from an upper surface of the first insulating layer, and forming a gate electrode on the gate insulating film and the first insulating film.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Card activated automated banking machine system and method

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Diebold Self-Service Systems Division Of Diebold, Incorporated patent solves the following problem:

Automated banking machine may include a card reader that operates to read information from a lead record as a user card. The automated banking machine may operate to cause the data read from the card compared to other computer stored data relating to the take. The machine operates in response to the comparison to determine that the lead is an authorized system user to do at least some transactions that are working to transfer money to or from at least one account. A record of transactions also usually printed through the operation of the automated banking machine and delivered to the user. A common type of automated banking machine used by consumers is an automated teller machine (ATM). ATM reading customer cards and enables customers to carry out banking transactions. Banking transactions carried out using the ATM may include sharing the cash, make deposits, transfer funds between accounts and account balance inquiries. The types of banking transactions a customer can carry out determined the capabilities of the particular banking machine and the programming of the institution operate the machine.

Our analysis of this patent is as follows:

Diebold Self-Service Systems Division Of Diebold, Incorporated’s patent US 8038057 B1 deals with Card activated automated banking machine system and method.
A card operated automated banking machine is operating to carry out financial transactions responsive to data included user cards. The machine includes a user interface including a display. The user interface includes a card reader that is operating in reading user data cards to identify at least one of a user and a financial account in a user. A machine fascia includes a keypad by which users input confidential data. Comprising prevent unauthorized people from seeing confidential inputs into the keypad. Approval signal assures that the display-operate in a way that provides an appropriate user instructions. A visual indicator is moving shows a user keypad inputs encrypted.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Articulating suturing device and method

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Abbott Laboratories patent solves the following problem:

The present invention relates generally to apparatus and methods for suturing of body lumens. Particularly, the present invention relates to techniques for percutaneous closure of arterial and venous puncture sites, which are often obtained through a tissue tract.

Our analysis of this patent is as follows:

Abbott Laboratories’s patent US 8038688 B2 deals with Articulating suturing device and method.
Devices, systems, and methods for suturing of body lumens to allow suturing of vascular puncture sites located at the distal end of a percutaneous tissue tract. An elongated articulated foot near a distal end of a shaft that is inserted through the penetration and operated so that the foot extends along the lumenal axis. The foot brings suturing arm feeling, and old needles from the shaft through the vessel wall outside penetration and engagement with the needle arm after foot drawn proximally against the endothelial surface of blood vessels. The cross-section of the shaft in the tissue tract alleviated by lapta deflecting the needles as they leave the shaft while tapered depressions in the foot may lead to advances in needle into engagement arm. The arms lockingly engage the needle to be withdrawn proximally along the needle paths and through the tissue tract to form a loop of suture across the puncture. The rubbing feet will be realigned to the shaft and went proximally through the tissue tract without dilating the tissue tract.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer

File for Quick & Easy Patent Protection with PowerPatent.

The Agensys, Inc. patent solves the following problem:

Cancer is the second leading cause of death in human disease. Worldwide, millions of people die from cancer every year. In the United States alone, as reported by the American Cancer Society, cancer causes the death of more than a half-million people annually, with over 1.2 million new cases diagnosed per year . While death from heart disease was significantly reduced, the result in cancer in general is on the rise. In the early part of the next century, cancer is predicted to become the leading cause of death.

Our analysis of this patent is as follows:

Agensys, Inc.’s patent US 8039603 B2 deals with Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer.
A novel gene (designated 121P1F1) protein and the symbolic, and this race, which describes 121P1F1 exhibits tissue specific expression in normal adult tissue, and aberrantly expressed in the cancers listed in Table I. Consequently, 121P1F1 provides a diagnostic, prognostic, prophylactic and / or therapeutic target for cancer. 121P1F1 gene or fragment thereof, or the symbolic protein, or race, or a portion thereof, may be used to obtain a humoral or cellular immune response; antibody or T cells reactive to 121P1F1 be used in active or passive immunization.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Logistical system and method for controlling flow of postal mail in real-time

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Electronics And Telecommunications Research Institute patent solves the following problem:

The present invention relates to a method and system for controlling the flow of postal mail in real-time, and especially, in a logistical system and method enables a device to manage postal mail from receipt to complete the delivery, based on a methodology for collecting data on the number of mail delivered; effective control of the burden placed on the postal agencies, postal centers (mail sorting centers; external and internal sorting centers), and collection and delivery centers (called collectively called the distribution center), based on the amount of mail collected; and efficiently do the delivery of mail collected; thus improving postal service quality in transparency and trust.

Our analysis of this patent is as follows:

Electronics And Telecommunications Research Institute’s patent US 8041452 B2 deals with Logistical system and method for controlling flow of postal mail in real-time.
A method and system for controlling the flow of postal mail in real-time given. The logistical system includes a pre-application processing system, a real-time mail plan and adjust the system, and a real-time working and planning work on the system. The pre-application processing system registers bulk mail inputted to a generating system, and trigger sending data and the number of data registered bulk mail. The real-time mail plan and adjust system collects predetermined quantities working plan to process the data rate for each distribution center, and set temporary vehicles in a number of delivery among the distribution center exceeds the processing capacity of the center of distribution. The real-time working plan and carry system used in the amount of data transfer in a number of letters to the processing of postal distribution center, and collects and compares the work plans from each of the postal distribution center .

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Methods and compositions for inhibition of angiogenesis

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Children’s Medical Center Corporation patent solves the following problem:

As used here, the term angiogenesis refers to the generation of new blood vessels into a tissue or organ. Under normal physiological conditions, humans or animals only undergo angiogenesis in very specific restricted situations. For example, angiogenesis is often observed in wound healing, fetal and embryonal development and formation of the corpus luteum, endometrium and placenta. The control of angiogenesis is a highly regulated system of angiogenic stimulators and inhibitors. The control of angiogenesis found altered in certain disease states and, in many cases, the pathological damage associated with the disease is related to uncontrolled angiogenesis.

Our analysis of this patent is as follows:

Children’s Medical Center Corporation’s patent US 8039488 B2 deals with Methods and compositions for inhibition of angiogenesis.
The present invention consists of a group of compounds that effectively inhibit angiogenesis. More specifically, thalidomide and various related compounds as starting thalidomide analogs, metabolites and hydrolysis products were shown to inhibit angiogenesis and to treat diseases that result in angiogenesis. Furthermore, antiinflammatory drugs, such as steroids and NSAIDS can inhibit angiogenesis dependent diseases, either alone or in combination with thalidomide and related compounds. Important, these compounds can be administered orally.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Agensys, Inc. patent solves the following problem:

Cancer is the second leading cause of death in human disease. Worldwide, millions of people die from cancer every year. In the United States alone, as reported by the American Cancer Society, cancer causes the death of more than a half-million people annually, with over 1.2 million new cases diagnosed per year . While death from heart disease was significantly reduced, the result in cancer in general is on the rise. In the early part of the next century, cancer is predicted to become the leading cause of death.

Our analysis of this patent is as follows:

Agensys, Inc.’s patent US 8039000 B2 deals with Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer.
A novel gene (designated 158P3D2) and the symbolic protein, and dialects, which describes 158P3D2 exhibits tissue specific expression in normal adult tissue, and aberrantly expressed in the cancers listed in Table I. Consequently, 158P3D2 provides a diagnostic, prognostic, prophylactic and / or therapeutic target for cancer. The 158P3D2 gene or fragment thereof, or the symbolic protein, or race, or a portion thereof, may be used to obtain a humoral or cellular immune response; antibody or T cells reactive with 158P3D2 can be used in active or passive immunization.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.